Multiplex-based molecular diagnostic assays offer the ability to detect a wide range of pathogens within a single diagnostic test. Syndromic approaches to test for meningitis allow clinicians to identify the cause of infection often in a near-patient, point of impact setting where rapid diagnosis aids faster clinical decision making and patient treatment.
Qnostics’ Meningitis/ Encephalitis Evaluation Panel covers a wide range of target pathogens, including Escherichia coli, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitides, Streptococcus agalactiae, Streptococcus pneumonia, Cytomegalovirus, Enterovirus, Herpes Simplex Virus 1, Herpes Simplex Virus 2, Human Herpes Virus 6, Human Parechovirus, Varicella-Zoster Virus, and Cryptococcus neoformans/ gattii.
NATtrol products are ready to use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel and to monitor assay-kit lot performance.
NATtrol products contain intact organisms and should be run in a manner similar to clinical specimens.